<DOC>
	<DOCNO>NCT01266681</DOCNO>
	<brief_summary>Persistent Atrial Fibrillation ( AF ) common distress cardiac arrhythmia account 1 % healthcare budget UK 's prevalence rising . Symptoms atrial fibrillation include palpitation , chest pain , shortness breath fatigue , quality life measure reduce patient persistent AF , increase stroke risk increase cause mortality rate . DC Cardioversion use restore normal sinus rhythm patient persistent AF . It high success rate reoccurence AF common . The use anti arrhythmic drug ( AADs ) augment number patient remain sinus rhythm one year , amiodarone currently superior . Unfortunately serious side affect . Dronedarone related drug design specifically minimise serious side affect approve use prominently management non permanent AF . However yet study post DC Cardioversion population . Patients persistent AF refer elective DC Cardioversionwill randomise receive either Amiodarone Dronedarone compare ability help maintain sinu rhythm post cardioverion one NHS hospital . Patients follow year post cardioversion see stay sinus rhythm . Ho : difference maintenance sinus rhythm use amiodarone dronedarone</brief_summary>
	<brief_title>Amiodarone Compared Dronedarone , Post Cardioversion Maintenance Sinus Rhythm</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>• Patients persAF require dc cardioversion . Patients must 18 year old . Patients give informed consent form prior participate study . Patients must warfarin least 4 week transoesphageal ECHO must perform time dc cardioversion . • Patient suffer unstable angina last 1 week . Patient myocardial infarction within last 2 month . Patient expect major cardiac surgery within last 2 month . Patient participate conflict study . Patient mentally incapacitate consent comply followup . Patient NYHA class III/ IV heart failure . Pregnancy . Patient suffers cardiac rhythm disorder . Recent coronary artery intervention factor suggest clinical instability ( ECG , clinical laboratory finding ) . GFR &lt; 30mls/min . Patients contraindication amiodarone dronedarone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>